HIV Infections Clinical Trial
Official title:
SOLVE IT: Real Risk Reduction for MSM
This study will evaluate the effectiveness of an interactive virtual environment computer game in reducing risky sexual behaviors among men who have sex with men.
HIV and sexually transmitted diseases (STDs) are a major public health concern worldwide.
Although prevalent across all groups of people, HIV/STDs have had a remarkable effect on men
who have sex with men (MSM), who accounted for 71% of all HIV infections among American males
in 2005. After years of decline, the number of HIV diagnoses appears to have increased for
MSM, especially within the black MSM population. Thus, new approaches geared for HIV
prevention and education and built on past HIV prevention methods are needed. New
technologies, such as interactive computer games, delivered in a modern and appealing manner
may gain or recapture the attention of MSM who have disregarded more traditional HIV
prevention and educational services. Socially Optimized Learning in a Virtual Environment
(SOLVE)-IT is an interactive virtual environment computer game, designed specifically for
MSMs, that simulates the emotional, interpersonal, and contextual narrative of an actual
sexual encounter and provides challenging decision-making opportunities. By promoting
development of self-regulatory and behavioral skills, SOLVE-IT may be an effective approach
to reduce sexual risk behaviors. This study will evaluate the effectiveness of SOLVE-IT in
reducing risky sexual behaviors among MSM.
Participation in this study will last 6 months from the beginning of treatment. All
participants will first undergo baseline assessments that will include questionnaires about
sexual behavior, drug use, health history, feelings, and beliefs. Participants will then be
assigned randomly to receive SOLVE-IT immediately or after a 6-month waitlist period.
SOLVE-IT will include two 1-hour sessions conducted on a computer over the Internet,
occurring at baseline and 6 months later. During sessions, participants will play an
interactive computer game that presents dating or sexual scenarios and allows participants to
choose how the scenarios unfold. Participants will repeat baseline questionnaires at Months 3
and 6 of follow-up. Participants in the waitlist group will be offered to receive SOLVE-IT
after completion of the Month 6 follow-up.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05454514 -
Automated Medication Platform With Video Observation and Facial Recognition to Improve Adherence to Antiretroviral Therapy in Patients With HIV/AIDS
|
N/A | |
| Completed |
NCT03760458 -
The Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less Than 12 Years of Age
|
Phase 1/Phase 2 | |
| Completed |
NCT03067285 -
A Phase IV, Open-label, Randomised, Pilot Clinical Trial Designed to Evaluate the Potential Neurotoxicity of Dolutegravir/Lamivudine/Abacavir in Neurosymptomatic HIV Patients and Its Reversibility After Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide. DREAM Study
|
Phase 4 | |
| Completed |
NCT03141918 -
Effect of Supplementation of Bioactive Compounds on the Energy Metabolism of People Living With HIV / AIDS
|
N/A | |
| Recruiting |
NCT04579146 -
Coronary Artery Disease (CAD) in Patients HIV-infected
|
||
| Completed |
NCT06212531 -
Papuan Indigenous Model of Male Circumcision
|
N/A | |
| Active, not recruiting |
NCT03256422 -
Antiretroviral Treatment Taken 4 Days Per Week Versus Continuous Therapy 7/7 Days Per Week in HIV-1 Infected Patients
|
Phase 3 | |
| Completed |
NCT03256435 -
Retention in PrEP Care for African American MSM in Mississippi
|
N/A | |
| Completed |
NCT00517803 -
Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other Immunodeficiencies
|
N/A | |
| Active, not recruiting |
NCT03572335 -
Systems Biology of Diffusion Impairment in Human Immunodeficiency Virus (HIV)
|
||
| Completed |
NCT04165200 -
Fecal Microbiota Transplantation as a Therapeutic Strategy for Patients Infected With HIV
|
N/A | |
| Recruiting |
NCT03854630 -
Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV Infection
|
Phase 4 | |
| Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A | |
| Completed |
NCT02234882 -
Study on Pharmacokinetics
|
Phase 1 | |
| Completed |
NCT01618305 -
Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 20 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission
|
Phase 4 | |
| Recruiting |
NCT05043129 -
Safety and Immune Response of COVID-19 Vaccination in Patients With HIV Infection
|
||
| Not yet recruiting |
NCT05536466 -
The Influence of Having Bariatric Surgery on the Pharmacokinetics, Safety and Efficacy of the Novel Non-nucleoside Reverse Transcriptase Inhibitor Doravirine
|
N/A | |
| Recruiting |
NCT04985760 -
Evaluation of Trimer 4571 Therapeutic Vaccination in Adults Living With HIV on Suppressive Antiretroviral Therapy
|
Phase 1 | |
| Completed |
NCT05916989 -
Stimulant Use and Methylation in HIV
|
||
| Terminated |
NCT02116660 -
Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants With Suppressed Viremia and Impaired Renal Function (MK-0518-284)
|
Phase 2 |